Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study will investigate the safety, tolerability, and pharmacokinetics of single ascending doses of emodepside (BAY 44-4400) in healthy male volunteers. This study will also conduct an exploratory investigation of the relative bioavailability of emodepside administered as tablets and determine the effect of food on the pharmacokinetics.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Additional exclusion criteria for cohort with ophthalmological assessments:
Primary purpose
Allocation
Interventional model
Masking
79 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal